Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 3,588,094 | 3,280,344 | 0 | 1,281,747 | 1,151,175 |
| Cost of Goods | 1,481,953 | 1,455,619 | N/A | 565,860 | 542,844 |
| Gross Profit | 2,106,140 | 1,824,720 | 940,750 | 715,880 | 752,340 |
| Operating Expenses | 1,494,692 | 1,439,468 | 235,790 | 538,424 | 620,720 |
| Operating Income | 612,402 | 385,876 | -235,790 | 178,323 | -11,545 |
| Interest Expense | 152,322 | 192,911 | 0 | 67,417 | 32,156 |
| Other Income | -18,528 | 1,581 | 0 | 28,290 | 147,764 |
| Pre-tax Income | 441,552 | 194,546 | -235,790 | 139,196 | 104,063 |
| Income Tax | 63,694 | 49,952 | N/A | 32,958 | 28,304 |
| Net Income Continuous | 378,288 | 144,594 | -235,790 | 106,238 | 75,759 |
| Net Income Discontinuous | 0 | 0 | N/A | 12,911 | -266,808 |
| Net Income | $378,295 | $144,594 | $-235,790 | $119,149 | $-191,049 |
| EBITDA(a) | $1,143,952 | $969,766 | $-58,380 | $315,873 | $152,635 |